Squarepoint’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $464K | Buy |
511,107
+153,335
| +43% | +$139K | ﹤0.01% | 1946 |
|
|
2025
Q1 | $162K | Buy |
357,772
+265,771
| +289% | +$120K | ﹤0.01% | 2422 |
|
|
2024
Q4 | $46.2K | Buy |
+92,001
| New | +$46.2K | ﹤0.01% | 2652 |
|
|
2024
Q3 | – | Sell |
-44,307
| Closed | -$44.2K | – | 2799 |
|
|
2024
Q2 | $44.2K | Sell |
44,307
-147,588
| -77% | -$147K | ﹤0.01% | 2374 |
|
|
2024
Q1 | $284K | Buy |
191,895
+18,597
| +11% | +$27.5K | ﹤0.01% | 1953 |
|
|
2023
Q4 | $189K | Buy |
173,298
+148,667
| +604% | +$162K | ﹤0.01% | 2155 |
|
|
2023
Q3 | $29.1K | Sell |
24,631
-7,294
| -23% | -$8.61K | ﹤0.01% | 2369 |
|
|
2023
Q2 | $45K | Sell |
31,925
-931
| -3% | -$1.31K | ﹤0.01% | 2297 |
|
|
2023
Q1 | $49.3K | Buy |
+32,856
| New | +$49.3K | ﹤0.01% | 2117 |
|